Selenium Cysteinate
Selenium cysteinate is a selenium-containing amino acid derivative in which selenium replaces the sulfur atom of cysteine, forming selenocysteine, the biologically active form incorporated into selenoproteins. It serves as a precursor to the 21st amino acid selenocysteine, which is encoded by the UGA codon and functions at the catalytic sites of antioxidant enzymes including glutathione peroxidase and thioredoxin reductase.

Origin & History
Selenium cysteinate (selenocysteine) is a naturally occurring selenium-containing amino acid where selenium replaces sulfur in the cysteine side chain, recognized as the 21st proteinogenic amino acid. It originates in both eukaryotic and prokaryotic organisms, incorporated into proteins via specialized tRNA and the TGA codon during translation. Rather than being extracted or isolated, it is synthesized enzymatically within cells via selenocysteine synthase from phosphoserine-tRNA.
Historical & Cultural Context
No historical or traditional medicinal uses of selenium cysteinate are documented, as it is a modern biochemical discovery recognized through genetic code research. The compound lacks any context in traditional medicine systems like Ayurveda, TCM, or herbalism.
Health Benefits
• No clinical evidence available - selenocysteine has not been studied as a supplement in human trials • Functions as part of glutathione peroxidase enzymes for antioxidant activity (mechanistic evidence only) • Contributes to formate dehydrogenase activity for cellular metabolism (mechanistic evidence only) • May influence nucleoside triphosphate synthesis pathways (mechanistic evidence only) • Potential antimicrobial activity through lipopolysaccharide binding (mechanistic evidence only)
How It Works
Selenium cysteinate supplies selenocysteine, which is co-translationally inserted into selenoproteins at UGA codons via a dedicated tRNA-Sec and elongation factor SelB complex. Once incorporated, the selenol group (-SeH) of selenocysteine acts as the catalytic nucleophile in glutathione peroxidase (GPx1–GPx4), reducing hydrogen peroxide and lipid hydroperoxides using glutathione as a cofactor. Selenocysteine also drives thioredoxin reductase (TrxR) activity, regenerating thioredoxin to maintain cellular redox balance and support formate dehydrogenase-mediated one-carbon metabolism.
Scientific Research
No human clinical trials, RCTs, or meta-analyses on selenium cysteinate as a supplement were identified in the research. The compound is primarily studied as an endogenous amino acid component of selenoproteins rather than as an isolated therapeutic agent. No PubMed PMIDs for human trials were available.
Clinical Summary
No published human clinical trials have specifically investigated selenium cysteinate or selenocysteine as an isolated oral supplement, leaving a complete absence of direct efficacy or dose-response data for this compound form. Broader selenium supplementation research—using selenomethionine or sodium selenite—provides indirect mechanistic context; for example, the Nutritional Prevention of Cancer (NPC) trial (n=1,312) and SELECT trial (n=35,533) studied selenium's role in cancer prevention but used different compound forms and produced mixed results. Mechanistic evidence from in vitro and animal studies confirms selenocysteine's indispensable role in GPx and TrxR enzyme function, but these findings cannot be extrapolated to supplemental efficacy claims in humans. The current evidence base is insufficient to support any therapeutic or preventive health claim specifically for selenium cysteinate supplementation.
Nutritional Profile
Selenium cysteinate (also referred to as selenocysteine or selenium bound to cysteine) is an organoselenium mineral supplement providing selenium in an amino acid-chelated form. Key nutritional details: **Primary active element:** Selenium (Se), typically delivering 50–200 mcg of elemental selenium per dose depending on formulation. The molecular complex consists of selenium coordinated with the amino acid cysteine (L-cysteine), yielding a molecular weight of approximately 168.06 g/mol (for selenocysteine, C₃H₇NO₂Se), of which selenium constitutes roughly 47% by weight. **Bioactive compounds:** The selenium is present in the selenol (-SeH) functional group analogous to the thiol (-SH) in cysteine, making it the direct precursor/analog of the 21st amino acid selenocysteine (Sec/U) found in selenoproteins. This form may also provide trace amounts of L-cysteine as a secondary nutrient (~0.07–0.12 mg per 100 mcg Se dose). **Bioavailability notes:** Organoselenium forms such as selenium cysteinate generally demonstrate superior absorption compared to inorganic selenium (selenite/selenate), with estimated intestinal absorption rates of 80–95% via active amino acid transport pathways (primarily the neutral amino acid transport system in the small intestine). However, selenium cysteinate is metabolically distinct from selenomethionine — it is not non-specifically incorporated into body proteins and instead is more directly channeled into selenoprotein synthesis or catabolized for excretion. This may result in more targeted but potentially lower tissue retention compared to selenomethionine. **Macronutrients:** Negligible — contains no significant calories, fat, carbohydrates, or fiber. Protein/amino acid contribution is trace (sub-milligram quantities of cysteine). **Other minerals/vitamins:** None unless specifically added by the manufacturer. **Recommended selenium intake reference:** Adult RDA for selenium is 55 mcg/day (US); tolerable upper intake level (UL) is 400 mcg/day. Selenium cysteinate supplements typically provide 100–200 mcg elemental Se per serving, representing 182–364% of the RDA. **Storage form consideration:** Unlike selenomethionine, selenium cysteinate does not accumulate in a non-specific methionine pool, so its selenium is considered more immediately bioavailable for functional selenoprotein (e.g., glutathione peroxidase, thioredoxin reductase, iodothyronine deiodinase) synthesis but with a shorter biological half-life.
Preparation & Dosage
No clinically studied dosage ranges are available for selenium cysteinate, as it has not been investigated as a supplement but only as a proteinogenic amino acid incorporated into proteins. The compound is highly unstable and oxidizable, making supplemental use impractical. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Glutathione, vitamin E, selenium (as selenomethionine), NAC, alpha-lipoic acid
Safety & Interactions
Selenium toxicity (selenosis) can occur at chronic intakes above 400 mcg/day in adults, causing hair loss, nail brittleness, garlic breath odor, and peripheral neuropathy; the tolerable upper intake level (UL) established by the Institute of Medicine is 400 mcg/day for adults. Selenium compounds may interact with cisplatin and other platinum-based chemotherapy agents, potentially altering cytotoxic efficacy, and may reduce the absorption of clozapine and valproic acid in some individuals. Selenium supplementation is generally considered safe during pregnancy at RDA levels (60 mcg/day), but high-dose supplementation has not been adequately studied in pregnant or lactating populations and should be avoided without medical supervision. Individuals with autoimmune thyroid conditions such as Hashimoto's thyroiditis should use selenium supplements cautiously, as both deficiency and excess can disrupt thyroid peroxidase and deiodinase selenoprotein function.